You are here: Industry Insights > RDIF

News List

S Korean consortium to produce Russia’s Sputnik Light vaccine expresspharma
June 29, 2021
Huons Global said that its South Korean consortium plans to begin production of a single-dose Sputnik Light COVID-19 vaccine from as early as September.
Test batch of the Sputnik V vaccine produced in Iran firstwordpharma
June 28, 2021
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Actoverco, one of Iran’s leading pharmaceutical companies, announce the production of a test batch of the Russian Sputnik V vaccine against coronavirus.
RDIF, UNICEF sign  agreement for supply of 220 million doses of Sputnik V vaccine expresspharma
May 31, 2021
Concurrently, RDIF will be holding a separate discussion with Gavi, the Vaccine Alliance to see the Sputnik V vaccine considered for inclusion in the COVAX Facility’s Portfolio of COVID-19 vaccines.
RDIF, Panacea Biotec launch production of Sputnik V in India expresspharma
May 25, 2021
The Russian Direct Investment Fund (RDIF) and Panacea Biotec announced the launch of production of the Russian Sputnik V vaccine against coronavirus.
Dr Reddy’s, RDIF in discussions on production of Sputnik V for other countries expresspharma
May 21, 2021
In addition, there are discussions with RDIF for Sputnik light, a single dose vaccine for COVID-19 being developed in Russia as well as additional engagement for the future for India, informed a senior official of Dr Reddy’s.
Russia authorises use of single-dose Covid-19 vaccine Sputnik Light pharmaceutical-technology
May 08, 2021
Sputnik Light, which is based on the human adenoviral vector platform, is the first component, a recombinant human adenovirus serotype number 26 (rAd26), of the Sputnik V Covid-19 vaccine.
RDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt prnasia
April 22, 2021
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), Egypt's Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary, ProBioGen AG, announce the agreement to produce over 40 million doses per ...
Russia’s Sputnik V Covid-19 vaccine shows 97.6% efficacy pharmaceutical-technology
April 20, 2021
The Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have reported that the Sputnik V Covid-19 vaccine showed a 97.6% efficacy.
RDIF, Hualan Ink COVID-19 Vaccine Deal contractpharma
April 20, 2021
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Hualan Biological Bacterin Inc., a subsidiary company of one of China’s leading biopharmaceutical producers and the largest influenza vaccine manufacturer ...
Working on stability data on 2 to 8 C, temp range for Sputnik V vaccine: Dr Reddy’s expresspharma
April 16, 2021
He said necessary cold storage infrastructure is in place to distribute the Sputnik V vaccine in India, which would be available during this quarter.

Previous page 1 2 3 4 5 Next page